Illness	Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	191
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	145
Obstructive uropathy and refluxuropathy - Pyonephrosis - Hydronephrosis in ureteral stricture not elsewhere classified with infection of the kidney (N13.61)	141
Calculus of kidney and ureter - Calculus of kidney (N20.0)	140
Volume depletion (E86)	137
Hyperplasia of prostate (N40)	132
Retention of urine (R33)	124
Unspecified haematuria (R31)	115
Malignant neoplasm of prostate (C61)	107
Complications of genitourinary prosthetic devices implants and grafts (T83.5)	101

Top 10 treatments

Treatment	Number
Examination of the urethra and the urinary bladder by endoscopy (1-661)	600
Injection or administration of medicines into the urinary bladder (8-132.3)	393
Insertion, exchange or removal of a ureteral stent (8-137.03)	293
(9-984.7)	286
(5-98k.2)	261
(9-984.8)	254
(5-98k.0)	228
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	189
Other computed tomography (CT) without contrast medium (3-20x)	180
Examination of the ureter and the renal pelvis with a tube-shaped instrument with a camera mounted at the end (endoscope) (5-98b.x)	175

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
16	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
11	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
11	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Doctoral supervision
Lectureships / teaching posts at colleges and universities

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB03	Physical therapist / physiotherapist (m/f)	Ausbildung in Kooperation
HB05	Medical technical radiology assistant (MTRA) (m/f)	Ausbildung in Kooperation
HB07	Surgical technical assistant (m/f)	Ausbildung in Kooperation
HB12	Medical technical laboratory assistant (MTLA) (m/f)	Ausbildung in Kooperation
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)	Ausbildung in Kooperation
HB15	Anaesthesia technical assistant (m/f)	Ausbildung in Kooperation
HB17	Auxiliary nurse (m/f)	Ausbildung in Kooperation
HB18	Emergency paramedics (m/f) (training period 3 years)	Ausbildung in Kooperation
HB19	Nursing professionals